Medtech company Aevice Health, based in Singapore and focused on remote respiratory monitoring systems, has raised USD 1 million from Japanese medtech company A&D.
Read also – Abu Dhabi-Based RedBird IMI Acquires All3Media for $1.45 Billion
This investment will support the launch of AeviceMD, the company’s flagship remote monitoring platform, in the US and Japan in addition to easing the integration of Aevice’s technology with A&D’s experience in medtech design and manufacture.
“We are delighted to announce our investment in Aevice Health. This collaboration will strengthen our ability to develop solutions for the health challenges facing society. We are eager to leverage our expertise and technology together to further our joint mission of improving patient care for those with respiratory conditions”, said Yasunobu Morishima, Representative Director and President of A&D Company, Limited.
The relationship between A&D Company, Limited and Aevice Health was enabled by JETRO Singapore, which was instrumental in establishing a connection and promoting cooperation between the two organisations.
Read also – Saudi Arabia-Based SaaS provider Merit Secures $12 Million in Pre-Series B Funding
With a smart wearable stethoscope appropriate for all age groups, AeviceMD is a patient management platform for managing chronic respiratory diseases that has received approval from the US FDA and the Singapore Health Services Authority. The platform is always keeping an eye out for biomarkers of interest, such wheezing and early indicators of exacerbation.
About Aevice Health
Aevice Health Pte Ltd, a Nanyang Technological University MedTech spin-off, is pioneering chronic respiratory disease treatment.
